Compared with dual antiplatelet therapy (DAPT), a de-escalated DAPT strategy resulted in similar graft occlusion rates and ...

Patients benefit from antiplatelet therapy after coronary-artery bypass grafting (CABG) for an acute coronary syndrome. Whether the addition of ticagrelor to aspirin, as compared with aspirin ...

Patients who underwent coronary artery bypass graft surgery and had elevated levels of the cardiac enzymes creatine kinase or troponin in the 24 hours following surgery had an associated ...

Coronary artery bypass grafting (CABG) or heart bypass surgery is an open heart surgery to relieve the blockages of the arteries of the heart. Coronary artery bypass surgery lasts up to 3 to 6 hours.

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years ...

In EXCEL and NOBLE, two trials studying PCI versus CABG surgery for left main coronary artery disease, the study duration was just 3 and 5 years, respectively. “Once we’re operating on 60-year-olds ...

Early CABG performed 2 to 3 days after ticagrelor cessation was noninferior to delayed CABG performed at 5 to 7 days for the outcome of severe or massive perioperative bleeding in patients with ...

The Statin Recapture Therapy Before Coronary Artery Bypass Grafting (START-CABG) is a large-scale study conducted at 8 European centers investigating the potential benefits of "reloading" patients 12 ...

The present study shows that 10% of patients undergoing noncardiac surgery within 1 year of CABG have an adverse outcome. Our study had several major findings. First, patients with an EF less than ...